BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29483219)

  • 21. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
    Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
    Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C; Caruso R; Franzè E; Rizzo A; Rotondi A; Monteleone I; Fantini MC; Pallone F; Monteleone G
    Mol Cancer Ther; 2011 Oct; 10(10):1969-81. PubMed ID: 21817114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced TLR4 Expression on Colon Cancer Cells After Chemotherapy Promotes Cell Survival and Epithelial-Mesenchymal Transition Through Phosphorylation of GSK3β.
    Chung YH; Kim D
    Anticancer Res; 2016 Jul; 36(7):3383-94. PubMed ID: 27354597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
    Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells.
    Zhu F; Zykova TA; Kang BS; Wang Z; Ebeling MC; Abe Y; Ma WY; Bode AM; Dong Z
    Gastroenterology; 2007 Jul; 133(1):219-31. PubMed ID: 17631144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Small Ras-like protein Ray/Rab1c modulates the p53-regulating activity of PRPK.
    Abe Y; Takeuchi T; Imai Y; Murase R; Kamei Y; Fujibuchi T; Matsumoto S; Ueda N; Ogasawara M; Shigemoto K; Kito K
    Biochem Biophys Res Commun; 2006 May; 344(1):377-85. PubMed ID: 16600182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of B3GNT7 gene expression in colon adenocarcinoma and its potential effect in the metastasis of colon cancer cells.
    Lu CH; Wu WY; Lai YJ; Yang CM; Yu LC
    Glycobiology; 2014 Apr; 24(4):359-67. PubMed ID: 24418929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model.
    Yokoi K; Thaker PH; Yazici S; Rebhun RR; Nam DH; He J; Kim SJ; Abbruzzese JL; Hamilton SR; Fidler IJ
    Cancer Res; 2005 May; 65(9):3716-25. PubMed ID: 15867367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
    Yang D; Qu J; Qu X; Cao Y; Xu L; Hou K; Feng W; Liu Y
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):575-86. PubMed ID: 26208739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin.
    Zaanan A; Cuilliere-Dartigues P; Guilloux A; Parc Y; Louvet C; de Gramont A; Tiret E; Dumont S; Gayet B; Validire P; Fléjou JF; Duval A; Praz F
    Ann Oncol; 2010 Apr; 21(4):772-780. PubMed ID: 19833818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
    Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
    World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of CGI-121, a novel PRPK (p53-related protein kinase)-binding protein.
    Miyoshi A; Kito K; Aramoto T; Abe Y; Kobayashi N; Ueda N
    Biochem Biophys Res Commun; 2003 Apr; 303(2):399-405. PubMed ID: 12659830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RSK activation via ERK modulates human colon cancer cells response to PTHrP.
    Calvo N; Carriere P; Martin MJ; Gentili C
    J Mol Endocrinol; 2017 Jul; 59(1):13-27. PubMed ID: 28385776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo.
    Moser C; Lang SA; Kainz S; Gaumann A; Fichtner-Feigl S; Koehl GE; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Ther; 2007 Nov; 6(11):2868-78. PubMed ID: 18025273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folinic acid does improve 5-fluorouracil activity in vivo. Results of a phase III study comparing 5-fluorouracil to 5-fluorouracil and folinic acid in advanced colon cancer patients.
    Bobbio-Pallavicini E; Porta C; Moroni M; Spaghi A; Casagranda I; Nastasi G
    J Chemother; 1993 Feb; 5(1):52-5. PubMed ID: 8459266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.
    Kim DJ; Li Y; Reddy K; Lee MH; Kim MO; Cho YY; Lee SY; Kim JE; Bode AM; Dong Z
    Cancer Res; 2012 Jun; 72(12):3060-8. PubMed ID: 22523035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
    Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to apoptosis is increased during metastatic dissemination of colon cancer.
    Oliver L; Cordel S; Barbieux I; LeCabellec MT; Meflah K; Grégoire M; Vallette FM
    Clin Exp Metastasis; 2002; 19(2):175-80. PubMed ID: 11964082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.